CAS No.:19216-56-9
Name: Prazosin
Details Introduction
TOXICITY DATA with REFERENCE：
| 1. |
orl-wmn TDLo:20 µg/kg:BPR,GIT |
AIMEAS Annals of Internal Medicine. 97 (1982),455. | ||
| 2. |
orl-man TDLo:1143 µg/kg:BPR |
AMSVAZ Acta Medica Scandinavica. 213 (1983),157. | ||
| 3. |
orl-hmn TDLo:280 µg/kg:CNS,CVS |
BMJOAE British Medical Journal. 2 (1976),508. | ||
| 4. |
orl-hmn TDLo:1260 µg/kg:CNS,KID |
BMJOAE British Medical Journal. 1 (1978),622. |
Consensus Reports：
SAFETY PROFILE：
Human systemic effects by ingestion of very small amounts: somnolence, hallucinations, distorted perceptions, changes in motor activity, decreased blood pressure, nausea or vomiting, and kidney effects. Experimental reproductive effects. When heated to decomposition it emits toxic fumes of NOx.
Standards and Recommendations：
Analytical Methods：
Related Searches
Other Product
- -
- -
- -
- -
- -
- -
- -
- -
- -
- (4S,6R)-6-{2-[(2-hydroxy-ethyl)-(4-methoxy-benzenesulfonyl)-amino]-ethoxy}-4-isopropyl-5,6-dihydro-4H-pyran-2-carboxylic acid allyl ester
- [1,4'-Bipiperidine]-1'-carboxylic acid, 4-(1H-indol-7-yl)-, ethyl ester
- 1,3,5-Tris(4-acetamidophenyl)penta-1,5-dione
- 1,5-Bis(3-aminophenyl)-3-(4-N,N-di-methylaminophenyl)penta-1,5-dione
- 1,5-Bis(4-acetamidophenyl)-3-phenylpenta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-(4-acetamido-phenyl)penta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-phenylpenta-1,5-dione